 |
On July 30, Songshan Lake Guanrong Biotechnology Medical Industry Forum and "Guanrong Plan" corporate product launch conference were held at the Songshan Lake Eco-City Science Popularization Museum. The picture shows the research institute of a biopharmaceutical company in Songshan Lake. Photographed by Nanfang Daily reporter Sun Junjie |
Nanfang Daily News (Reporter/Huang Shaohong) On July 30, the Songshan Lake Guanrong Biotechnology Medical Industry Forum and the "Guanrong Plan" corporate product launch conference were held at the Songshan Lake Eco-City Science Popularization Museum. Song Tao, consultant to the Dongguan Municipal Government and chairman of Dongguan Biotechnology Industry Development Co., Ltd., Du Weihong and Huang Dehong, members of the Songshan Lake Management Committee, as well as the heads of the "Guanrong Plan" enterprises, representatives of Dongguan Biomedicine related enterprises, and Pearl River Delta Biomedicine Nearly 100 representatives from investment institutions participated in the matchmaking meeting. During the event, 20 "Guanrong Plan" companies released the first batch of products on site, and conducted in-depth docking with participating companies and institutions on research, production, marketing and other fields.
builds a platform to allow Taiwanese enterprises to take root and grow into trees and forests.
The "Guanrong Plan" is an initiative of the Dongguan Municipal People's Government to quickly introduce outstanding biotechnology companies from Taiwan and other places to settle in Dongguan for development, quickly promote innovative biotechnology industry clusters, and thus accelerate the development of cross-strait biotechnology. The construction of the technology industry cooperation base has promoted it to become an important starting point for the city's transformation and upgrading, and the biotechnology industry policy has been approved and implemented. By the end of 2017, all 20 biotechnology companies that met the selection criteria of the "Guanrong Plan" had settled in Songshan Lake, Dongguan, completing the introduction goals set by the "Guanrong Plan". These 20 biotechnology companies involve medical devices, IVD (in vitro diagnostic products), health food, medical cosmetology and other subdivided biological industries. They are all representative of the biotechnology industries in Hong Kong and Taiwan.
Song Tao said at the press conference that the reason why the "Guanrong Plan" has achieved today's results is inseparable from the efforts of the two major implementation platforms of the "Guanrong Plan" and all members of the special working group, but more importantly, it comes from It is driven by the core desire of enterprises in Taiwan and Hong Kong to expand into the mainland market. After 20 companies are launched, more than 80 high-tech biotechnology products of different specifications will enter the market or enter the registration and application stage. At the same time, facing broad market prospects and relatively unfamiliar environmental conditions, they hope that the platform can provide all-round assistance in biotech product registration, market access, and sales channels.
In order to better serve the biotechnology companies selected for the "Guanrong Plan", we actively promote the external exchanges and cooperation of the "Guanrong Plan" companies in Songshan Lake. The biotechnology company and Hugui Xingye will join hands with the companies to organize a series of "Guanrong Plan" brands Promotional activity - Songshan Lake Guanrong Biotechnology and Medical Industry Forum, hoping to use this platform to promote exchanges in the biotechnology industry.
On July 26, the Guangdong Provincial Government issued "Several Measures to Promote Economic and Cultural Exchanges and Cooperation between Guangdong and Taiwan", including 13 categories and a total of 48 measures, ranging from project introduction, technology research and development, land security, market expansion, finance, and professional qualifications , employment and entrepreneurship, etc., provide Taiwan compatriots with the same treatment as Guangdong enterprises and residents in investment, entrepreneurship, employment and life in Guangdong.
Song Tao said that this is an all-round, in-depth and high-quality integrated development of Guangdong and Taiwan in the new era, which will also be more conducive to the in-depth advancement of the "Guanrong Plan", allowing enterprises to take root as soon as possible and grow into trees and forests.
High-tech products and health products shine together. At the press conference, Dong Binghuang, general manager of Dongguan Jinhong Medical Equipment Co., Ltd., Zhong Xiangfeng, chairman of Murad Jiajie Biotechnology Co., Ltd., and director of Yanchen Biotechnology Pharmaceutical Co., Ltd. Entrepreneurs such as Changhuang Zhongyang, Tang Shangwen, Chairman of Jinghuatang Industrial Co., Ltd., Cai Wencheng, Chairman of the Board of Directors of Yongsheng Medical Holdings Co., Ltd., Gao Rongyue, General Manager of Dongguan Yibai Medical Technology Co., Ltd., discussed the core competitive advantages, core products and market strategies of their respective fields. Planning gave a keynote speech.
This product release matchmaking meeting also set up a special technology and product display area. The 20 companies selected for the "Guanrong Plan" exhibited their core products. Some of the technical achievements were eye-opening. The local pharmaceutical companies participating in the meeting A lively exchange and discussion was held with representatives of enterprises participating in the "Guanrong Plan" to learn about the introduced related technologies and products, and to discuss opportunities and models for cooperation. For example, Dongguan Yibai Medical Technology Co., Ltd. is displaying high-end medical equipment in the exhibition area. Its core technology is optical positioning and navigation technology, which has been applied in the fields of dentistry and surgery. According to the company's general manager Gao Rongyue, among the products released on site, Simex has been sold to more than 30 dental universities in China. Iris-100 has obtained the CFDA Class III dental implant navigation medical material certification in mainland China. It is the first manufacturer in mainland China to obtain the registration certificate for this type of product. This product allows dentists to display the drill bit position in real time during implant surgery. Monitor depth and angle to achieve precise implantation. The Retina surgical minimally invasive navigation system has obtained Taiwan product registration certificate, and the company has planned to start production in Songshan Lake.
According to the organizer, next, Dongguan Biotechnology Company will work with Taiwan Hugui Industrial as the implementation entity of the "Guanrong Plan", relying on the brand effect of the "Guanrong Plan" to build a regional-level Dongguan-Taiwan biotech medical research, production and marketing cooperation platform , guiding new products and new technologies of selected companies to quickly enter the market.
